Q4 2025 earnings call recap: production and EBITDA highlights, 2026 guidance, Power JV PPA timeline, and CCUS targets—read key takeaways.
The next-generation syringe is now approved for use in the EU, the U.S., and Canada with the NASHA ® lidocaine range of Restylane products including, Restylane Lyft™ Lidocaine, Restylane Eyelight™ and ...
A newly disclosed security issue in the popular jsPDF library has raised serious concerns for web developers. The flaw could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results